SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report

SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report

Abstract Despite severe immunosuppression due to conditioning chemotherapy for acute myeloid leukemia, COVID‐19 did not lead to clinical deterioration or death, thus raising the question of the impact of immunosuppressive treatment on clinical course evolution.

Bibliographic Details
Main Authors: Van Uytvanck Alexandra, Wittnebel Sebastian, Meuleman Nathalie, Loizidou Angela, Salengros Jean‐Corentin, Spilleboudt Chloé
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Clinical Case Reports
Subjects:
Aplasia
acute myeloid leukemia
SARS‐CoV‐2
Online Access:https://doi.org/10.1002/ccr3.4439
id doaj-a39f0da6908f42128ab901425ac75adb
record_format Article
spelling doaj-a39f0da6908f42128ab901425ac75adb2021-07-29T07:58:45ZengWileyClinical Case Reports2050-09042021-07-0197n/an/a10.1002/ccr3.4439SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case reportVan Uytvanck Alexandra0Wittnebel Sebastian1Meuleman Nathalie2Loizidou Angela3Salengros Jean‐Corentin4Spilleboudt Chloé5Institut Jules Bordet Brussels BelgiumDepartment of HaematologyInstitut Jules Bordet Brussels BelgiumDepartment of HaematologyInstitut Jules Bordet Brussels BelgiumInfectious DiseaseInstitut Jules Bordet Brussels BelgiumDepartment of AnaesthesiologyInstitut Jules Bordet Brussels BelgiumDepartment of HaematologyInstitut Jules Bordet Brussels BelgiumAbstract Despite severe immunosuppression due to conditioning chemotherapy for acute myeloid leukemia, COVID‐19 did not lead to clinical deterioration or death, thus raising the question of the impact of immunosuppressive treatment on clinical course evolution.https://doi.org/10.1002/ccr3.4439Aplasiaacute myeloid leukemiaSARS‐CoV‐2
collection DOAJ
language English
format Article
sources DOAJ
author Van Uytvanck Alexandra
Wittnebel Sebastian
Meuleman Nathalie
Loizidou Angela
Salengros Jean‐Corentin
Spilleboudt Chloé
spellingShingle Van Uytvanck Alexandra
Wittnebel Sebastian
Meuleman Nathalie
Loizidou Angela
Salengros Jean‐Corentin
Spilleboudt Chloé
SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
Clinical Case Reports
Aplasia
acute myeloid leukemia
SARS‐CoV‐2
author_facet Van Uytvanck Alexandra
Wittnebel Sebastian
Meuleman Nathalie
Loizidou Angela
Salengros Jean‐Corentin
Spilleboudt Chloé
author_sort Van Uytvanck Alexandra
title SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
title_short SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
title_full SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
title_fullStr SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
title_full_unstemmed SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report
title_sort sars‐cov‐2 infection in hematological patients during allogenic stem cell transplantation: a double case report
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2021-07-01
description Abstract Despite severe immunosuppression due to conditioning chemotherapy for acute myeloid leukemia, COVID‐19 did not lead to clinical deterioration or death, thus raising the question of the impact of immunosuppressive treatment on clinical course evolution.
topic Aplasia
acute myeloid leukemia
SARS‐CoV‐2
url https://doi.org/10.1002/ccr3.4439
work_keys_str_mv AT vanuytvanckalexandra sarscov2infectioninhematologicalpatientsduringallogenicstemcelltransplantationadoublecasereport
AT wittnebelsebastian sarscov2infectioninhematologicalpatientsduringallogenicstemcelltransplantationadoublecasereport
AT meulemannathalie sarscov2infectioninhematologicalpatientsduringallogenicstemcelltransplantationadoublecasereport
AT loizidouangela sarscov2infectioninhematologicalpatientsduringallogenicstemcelltransplantationadoublecasereport
AT salengrosjeancorentin sarscov2infectioninhematologicalpatientsduringallogenicstemcelltransplantationadoublecasereport
AT spilleboudtchloe sarscov2infectioninhematologicalpatientsduringallogenicstemcelltransplantationadoublecasereport
_version_ 1721259185755127808

Similar Items